e-learning
resources
Vienna 2012
Saturday, 01.09.2012
PG11 Pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cellular plasticity in lung fibrosis: where are all the fibroblasts coming from?
R. Strieter (Cambridge, United States of America)
Source:
Annual Congress 2012 - PG11 Pulmonary fibrosis
Session:
PG11 Pulmonary fibrosis
Session type:
Postgraduate Course
Number:
96
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Strieter (Cambridge, United States of America). Cellular plasticity in lung fibrosis: where are all the fibroblasts coming from?. Annual Congress 2012 - PG11 Pulmonary fibrosis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Location or origin? What is critical for macrophage propagation of lung fibrosis?
Source: Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018
Year: 2018
The fate of lung fibrosis: Reversible or not?
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010
Regulation of immune cells in lung fibrosis: the reign of regnase-1?
Source: Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020
Year: 2021
Fibroblasts from IPF explanted lungs have mitochondrial dysfunction and short telomeres leading to an increased senescence phenotype
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Opening Lecture: Is human pulmonary fibrosis simply lung regeneration without a blueprint?
Source: ERS Lung Science Conference 2021
Year: 2021
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?
Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017
Year: 2017
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Alveolar epithelial cell plasticity in lung injury, repair and fibrosis
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
The mitochondrion revisited: an overview of its role in lung inflammation and lung ageing
Source: ERS Lung Science Conference 2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept